Scientists studied the use of Chirayita and T. arjuna extracts to improve the antibacterial properties of glass ionomer cement used in dental restorations. This could potentially reduce the risk of cavity-causing microorganism growth.
Scientists studied the plant Terminalia arjuna, which is traditionally used in India for treating diseases. Its potential pharmacological activities are being investigated for potential use in repurposing drugs. Relevant for drug development.
This study explores the acetylcholinesterase-inhibitory potential of various compounds found in the bark of (Combreatceae). Arjunetin and arjunglucoside I can cross the blood-brain barrier. These compounds show potential as cognition-enhancing agents and have a high binding energy. The kinetics of AChE inhibition were also tested.
Researchers used network pharmacology and docking analysis to explore the potential of Arjuna in treating congestive cardiac failure (CCF). They identified several active compounds in Arjuna that target specific genes and signaling pathways, suggesting its potential as a preventive treatment for CCF.
Arjunolic acid is a natural compound found in a plant called Combretaceae. It has cardiovascular protective effects, but we don't know how it works exactly.